Preclinical data had suggested reducing serotonin might improve symptoms of pulmonary arterial hypertension, but new phase 2b ...

The Prescription Drug User Fee Act (PDUFA) date refers to the deadline set by the US Food and Drug Administration (FDA) for reviewing a New Drug ...

The growth of the most aggressive and deadly brain cancer, glioblastoma, was effectively suppressed in both ex vivo human ...

Two antidepressants appeared to improve verbal memory in moderate to severe depression, an effect linked to changes in ...

After the FDA declined to approve Lykos Therapeutics’ MDMA-assisted therapy for post-traumatic stress disorder, companies are ...

While momentous, the approval of Cobenfy could also draw attention to an age-old problem in American healthcare: Will insurance barriers keep patients from getting an effective medicine?

Zmyra stands out as a potent natural over-the-counter alternative to Ozempic. It provides a comprehensive weight loss ...

A recent trial shows that people with depression experienced greater symptom relief after 6 months of treatment with ...

Cognitive tests before and after use of a medication prescribed for mood disorders may improve our thinking abilities.

By focusing on the antidepressant escitalopram and its impact on one particular serotonin receptor, the 5HT4 receptor, this ...